Common Sense Overview
- Year Founded
-
1999
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$500K
Common Sense General Information
Description
Manufacturer of non-invasive diagnostic products for women designed to classify common abnormal vaginal discharges. The company's products use a testing technology that can be embedded into products, including panty liners, that assess for vaginal bacterial infections, as well as for amniotic-fluid leaks during the final phase of pregnancy, enabling women to track their health via color coding and act accordingly.
Contact Information
Website
www.peptonicmi.comCorporate Office
- 7 Ha'Eshel, Zone 2 Caesarea Industrial Park
- Caesarea 38900
- Israel
Corporate Office
- 7 Ha'Eshel, Zone 2 Caesarea Industrial Park
- Caesarea 38900
- Israel
Common Sense Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Merger/Acquisition | 06-Oct-2021 | $500K | Completed | Generating Revenue | ||
| 3. Out of Business | 01-Jan-2018 | Cancelled | Generating Revenue | |||
| 2. Secondary Transaction - Private | 01-Feb-2014 | $5M | Completed | Generating Revenue | ||
| 1. Early Stage VC | $5M | $5M | Completed | Generating Revenue |
Common Sense Patents
Common Sense Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2015283587-A1 | Diagnostic composition for identifying amniotic fluid | Active | 01-Jul-2014 | ||
| AU-2015283587-B2 | Diagnostic composition for identifying amniotic fluid | Active | 01-Jul-2014 | ||
| AU-2019204327-A1 | Diagnostic composition for identifying amniotic fluid | Active | 01-Jul-2014 | ||
| AU-2019204327-B2 | Diagnostic composition for identifying amniotic fluid | Active | 01-Jul-2014 | ||
| CA-2953886-A1 | Diagnostic composition for identifying amniotic fluid | Active | 01-Jul-2014 | A61L15/56 |
Common Sense Former Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| BioMedical Innovations Management | Venture Capital | Minority | ||
| Fishman Group | PE/Buyout | Minority | ||
| Foriland Investments | Venture Capital | Minority | ||
| Israel Technology Partners | Venture Capital | Minority | ||
| Latartech Holdings | Venture Capital | Minority |
Common Sense FAQs
-
When was Common Sense founded?
Common Sense was founded in 1999.
-
Where is Common Sense headquartered?
Common Sense is headquartered in Caesarea, Israel.
-
What industry is Common Sense in?
Common Sense’s primary industry is Diagnostic Equipment.
-
Is Common Sense a private or public company?
Common Sense is a Private company.
-
What is the current valuation of Common Sense?
The current valuation of Common Sense is .
-
What is Common Sense’s current revenue?
The current revenue for Common Sense is .
-
How much funding has Common Sense raised over time?
Common Sense has raised $5M.
-
Who are Common Sense’s investors?
BioMedical Innovations Management, Fishman Group, Foriland Investments, Israel Technology Partners, and Latartech Holdings are 5 of 7 investors who have invested in Common Sense.
-
When was Common Sense acquired?
Common Sense was acquired on 06-Oct-2021.
-
Who acquired Common Sense?
Common Sense was acquired by PEPTONIC Medical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process